KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Other financing activities (2016 - 2021)

Idexx Laboratories has reported Other financing activities over the past 11 years, most recently at $2.6 million for Q4 2021.

  • Quarterly results put Other financing activities at $2.6 million for Q4 2021, up 8733.33% from a year ago — trailing twelve months through Dec 2021 was $2.7 million (down 46.53% YoY), and the annual figure for FY2025 was $3.7 million, changed.
  • Other financing activities for Q4 2021 was $2.6 million at Idexx Laboratories, up from $30000.0 in the prior quarter.
  • Over the last five years, Other financing activities for IDXX hit a ceiling of $5.0 million in Q2 2020 and a floor of $7000.0 in Q3 2020.
  • Median Other financing activities over the past 3 years was $30000.0 (2019), compared with a mean of $1.1 million.
  • Biggest five-year swings in Other financing activities: crashed 41.67% in 2020 and later soared 8733.33% in 2021.
  • Idexx Laboratories' Other financing activities stood at $12000.0 in 2019, then surged by 150.0% to $30000.0 in 2020, then soared by 8733.33% to $2.6 million in 2021.
  • The last three reported values for Other financing activities were $2.6 million (Q4 2021), $30000.0 (Q4 2020), and $7000.0 (Q3 2020) per Business Quant data.